Filing Details

Accession Number:
0001171843-17-007734
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-12-18 17:11:00
Reporting Period:
2017-12-15
Accepted Time:
2017-12-18 17:11:00
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1359931 Proteon Therapeutics Inc PRTO Biological Products, (No Disgnostic Substances) (2836) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1619834 Keith Steven Burke C/o Proteon Therapeutics
200 West Street
Waltham MA 02451
Svp And Chief Medical Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2017-12-15 12,000 $1.88 117,535 No 4 P Direct
Common Stock Disposition 2017-12-15 3,334 $0.00 114,201 No 5 G Direct
Common Stock Disposition 2017-12-15 3,333 $0.00 110,868 No 5 G Direct
Common Stock Disposition 2017-12-15 3,333 $0.00 107,535 No 5 G Direct
Common Stock Acquisiton 2017-12-15 3,333 $0.00 8,333 No 5 G Indirect See footnote
Common Stock Acquisiton 2017-12-15 3,333 $0.00 11,666 No 5 G Indirect See footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 5 G Direct
No 5 G Direct
No 5 G Direct
No 5 G Indirect See footnote
No 5 G Indirect See footnote
Footnotes
  1. The purchase price of $1.88 is reflective of the weighted average purchase price of all transactions reported on this line. The prices for the transactions reported on this line range from $1.875 to $1.9. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
  2. This transaction involved a gift of securities by the reporting person to the William Conroy Burke Irrevocable Trust u/a 12/28/1998, an irrevocable trust established by the reporting person for the benefit of his son. The reporting person disclaims beneficial ownership of the shares held by his son, and this report should not be deemed an admission that the reporting person is the beneficial owner of his son's shares for purposes of Section 16 or for any other purpose.
  3. This transaction involved a gift of securities by the reporting person to the Timothy Andrew Burke Irrevocable Trust u/a 12/28/1998, an irrevocable trust established by the reporting person for the benefit of his son, who is deemed to share the reporting person's household. The reporting person disclaims beneficial ownership of the shares held by his son, and this report should not be deemed an admission that the reporting person is the beneficial owner of his son's shares for purposes of Section 16 or for any other purpose.
  4. This transaction involved a gift of securities by the reporting person to the Steven Edward Burke Irrevocable Trust u/a 11/15/2000, an irrevocable trust established by the reporting person for the benefit of his son, who is deemed to share the reporting person's household. The reporting person disclaims beneficial ownership of the shares held by his son, and this report should not be deemed an admission that the reporting person is the beneficial owner of his son's shares for purposes of Section 16 or for any other purpose.